Next week, the brightest lights of the psychedelic cognoscenti will gather in San Jose, California. Leaving swirls of tracer visions in their wakes, they will converge from around the world at an incongruously bland Holiday Inn, 50 miles south of the Haight-Ashbury neighborhood that once served as the pulsing capital of Psychedelistan. There, several hundred turned-on and tuned-in doctors, psychologists, artists and laypeople will participate in the annual conference of the Multidisciplinary Association for Psychedelic Studies (MAPS). For four days, they will explore — through workshops and lectures, nothing more — the widening gamut of clinical inquiry into the uses of the psychedelic experience, a global resurgence of which has led to hopeful talk of a “psychedelic revival.”
[From How Stanislav Grof Helped Launch the Dawn of a New Psychedelic Research Era | Drugs | AlterNet]